Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia

Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 pa...

Full description

Saved in:
Bibliographic Details
Published inBMC pulmonary medicine Vol. 20; no. 1; pp. 245 - 9
Main Authors Rousan, Liqa A., Elobeid, Eyhab, Karrar, Musaab, Khader, Yousef
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 15.09.2020
BioMed Central
BMC
Subjects
Adolescent
Adult
Aged
Aged, 80 and over
Asymptomatic
Chest
Chest x-rays
Child
Child, Preschool
Computed tomography
Consolidation
Coronavirus Infections - diagnostic imaging
Coronaviruses
COVID-19
Demography
Diagnosis
Female
Humans
Illnesses
Lung
Lung - diagnostic imaging
Male
Medical imaging
Middle Aged
Pandemics
Patients
Physiological aspects
Pleural effusion
Pneumonia
Pneumonia, Viral - diagnostic imaging
Polymerase chain reaction
Pulmonology
Radiography, Thoracic
Respiratory diseases
Retrospective Studies
Reverse transcription
Severe acute respiratory syndrome coronavirus 2
Time Factors
Tomography, X-Ray Computed
X-rays
Young Adult
Jordan
China
Online AccessGet full text

Cover

Abstract Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients. From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients' demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients' symptoms. A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 ± 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6-11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12-17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6-11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005). Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
AbstractList Background Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients. Methods From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients' demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients' symptoms. Results A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 [+ or -] 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6-11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12-17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6-11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005). Conclusion Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients.BACKGROUNDChest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients.From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients' demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients' symptoms.METHODSFrom March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients' demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients' symptoms.A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 ± 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6-11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12-17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6-11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005).RESULTSA total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 ± 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6-11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12-17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6-11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005).Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.CONCLUSIONAlmost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
Abstract Background Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients. Methods From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients’ demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients’ symptoms. Results A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 ± 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6–11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12–17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6–11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005). Conclusion Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
Background Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients. Methods From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients’ demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients’ symptoms. Results A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 ± 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6–11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12–17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6–11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005). Conclusion Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients. From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients' demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients' symptoms. A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 [+ or -] 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6-11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12-17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6-11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005). Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia. The study aims at describing the chest x-ray findings and temporal radiographic changes in COVID-19 patients. From March 15 to April 20, 2020 patients with positive reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were retrospectively studied. Patients' demographics, clinical characteristics, and chest x-ray findings were reported. Radiographic findings were correlated with the course of the illness and patients' symptoms. A total of 88 patients (50 (56.8%) females and 38 (43.2%) males) were admitted to the hospital with confirmed COVID-19. Their age ranged from 3 to 80 years (35.2 ± 18.2 years). 48/88 (45%) were symptomatic, only 13/88 (45.5%) showed abnormal chest x-ray findings. A total of 190 chest x-rays were obtained for the 88 patients with a total of 59/190 (31%) abnormal chest x-rays. The most common finding on chest x-rays was peripheral ground glass opacities (GGO) affecting the lower lobes. In the course of illness, the GGO progressed into consolidations peaking around 6-11 days (GGO 70%, consolidations 30%). The consolidations regressed into GGO towards the later phase of the illness at 12-17 days (GGO 80%, consolidations 10%). There was increase in the frequency of normal chest x-rays from 9% at days 6-11 up to 33% after 18 days indicating a healing phase. The majority (12/13, 92.3%) of patients with abnormal chest x-rays were symptomatic (P = 0.005). Almost half of patients with COVID-19 have abnormal chest x-ray findings with peripheral GGO affecting the lower lobes being the most common finding. Chest x-ray can be used in diagnosis and follow up in patients with COVID-19 pneumonia.
ArticleNumber 245
Audience Academic
Author Rousan, Liqa A.
Karrar, Musaab
Khader, Yousef
Elobeid, Eyhab
Author_xml – sequence: 1
  givenname: Liqa A.
  orcidid: 0000-0002-9589-7759
  surname: Rousan
  fullname: Rousan, Liqa A.
– sequence: 2
  givenname: Eyhab
  surname: Elobeid
  fullname: Elobeid, Eyhab
– sequence: 3
  givenname: Musaab
  surname: Karrar
  fullname: Karrar, Musaab
– sequence: 4
  givenname: Yousef
  surname: Khader
  fullname: Khader, Yousef
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32933519$$D View this record in MEDLINE/PubMed
BookMark eNp9Uttu1DAQjVARvcAP8IAs8cJLiu-xX5Cq5bZSpUoIeLUmjpP1KrGXOCn073G6LXQrhCzLo_GZMz7jc1ochRhcUbwk-JwQJd8mQpXGJaZ551CW4klxQnhFSsqlPHoQHxenKW0xJpUS7FlxzKhmTBB9UnxZbVya0K9yhBvU-tD40CUEoUGTG3ZxhB71c-iQ3UDoXEI-oB1M3oUpoZ9-2qDV1ff1-5JotAtuHmLw8Lx42kKf3Iu786z49vHD19Xn8vLq03p1cVlaIdlU1ljZFipJLNacV8JZArXkoOrKtflxbeu4ZlhXmAoqgYFQrWC1qyXhvK4YOyvWe94mwtbsRj_AeGMieHObiGNnYJy87Z0BokCq3Aww4bqRylUUc6uFIDWlxGaud3uu3VwPrrFZX5Z-QHp4E_zGdPHaVFyTPNZM8OaOYIw_5jxSM_hkXd9DcHFOhnK-DBxzkaGvH0G3cR5DHtWC4oQyLvhfVAdZgA9tzH3tQmouJJOaC6xlRp3_A5VX4wZvs11an_MHBa8eCv2j8N4RGaD2ADvGlEbXGuun_ONx0e17Q7BZzGf25jPZfObWfGYRRh-V3rP_p-g3izHYKw
CitedBy_id crossref_primary_10_1038_s41598_022_24721_5
crossref_primary_10_1007_s12045_023_1530_7
crossref_primary_10_3390_app12083895
crossref_primary_10_1155_2021_5513679
crossref_primary_10_2139_ssrn_4137562
crossref_primary_10_1155_2021_4496488
crossref_primary_10_2217_fvl_2021_0118
crossref_primary_10_3390_bioengineering10080946
crossref_primary_10_1080_21681163_2023_2250861
crossref_primary_10_3389_fped_2024_1420196
crossref_primary_10_1080_21505594_2021_1972201
crossref_primary_10_1109_TCBB_2022_3190265
crossref_primary_10_1109_ACCESS_2021_3083516
crossref_primary_10_4103_mjdrdypu_mjdrdypu_753_21
crossref_primary_10_3390_tropicalmed8050268
crossref_primary_10_22159_ijcpr_2023v15i4_3033
crossref_primary_10_1038_s41598_024_67536_2
crossref_primary_10_1016_j_ejro_2021_100385
crossref_primary_10_1016_j_eswa_2023_121724
crossref_primary_10_1007_s10140_022_02105_6
crossref_primary_10_1016_j_rx_2021_03_004
crossref_primary_10_1038_s41598_022_15013_z
crossref_primary_10_1371_journal_pone_0263922
crossref_primary_10_1007_s00521_023_08341_2
crossref_primary_10_1111_joim_13646
crossref_primary_10_1177_20503121241275369
crossref_primary_10_1088_2057_1976_ac8939
crossref_primary_10_3390_biomed1020011
crossref_primary_10_3390_diagnostics13122091
crossref_primary_10_7759_cureus_23431
crossref_primary_10_3390_bioengineering9110709
crossref_primary_10_1016_j_ijregi_2024_01_006
crossref_primary_10_7861_clinmed_2023_0059
crossref_primary_10_4103_jmms_jmms_42_21
crossref_primary_10_1159_000516325
crossref_primary_10_1186_s13634_021_00755_1
crossref_primary_10_7759_cureus_36330
crossref_primary_10_4329_wjr_v14_i7_219
crossref_primary_10_3390_app12136364
crossref_primary_10_22141_2224_0551_19_6_2024_1746
crossref_primary_10_3390_bios12050299
crossref_primary_10_1111_1754_9485_13361
crossref_primary_10_1016_j_compbiomed_2021_104605
crossref_primary_10_22207_JPAM_18_1_51
crossref_primary_10_3390_diseases12120310
crossref_primary_10_1016_j_compbiomed_2021_105134
crossref_primary_10_1007_s00500_021_06579_3
crossref_primary_10_3389_fcvm_2021_638011
crossref_primary_10_4103_jfmpc_jfmpc_307_23
crossref_primary_10_1038_s41591_024_03214_0
crossref_primary_10_1053_j_ro_2021_10_002
crossref_primary_10_3389_fped_2021_634844
crossref_primary_10_3390_diagnostics12020267
crossref_primary_10_3390_healthcare10122443
crossref_primary_10_1016_j_jsps_2021_08_008
crossref_primary_10_3390_app11198867
crossref_primary_10_1097_TME_0000000000000418
crossref_primary_10_3390_s22135007
crossref_primary_10_1891_11_T_729
crossref_primary_10_7759_cureus_24864
crossref_primary_10_1080_17476348_2022_1987885
crossref_primary_10_1097_MCC_0000000000000792
crossref_primary_10_3390_computers13050109
crossref_primary_10_1007_s12272_021_01331_9
crossref_primary_10_5812_jkums_119539
crossref_primary_10_1016_j_clinimag_2021_08_019
crossref_primary_10_1002_jmrs_852
crossref_primary_10_1177_20552076221092543
crossref_primary_10_36106_ijsr_6401648
crossref_primary_10_1186_s12911_023_02136_0
crossref_primary_10_1136_bcr_2021_243760
crossref_primary_10_7861_clinmed_2021_0124
crossref_primary_10_3390_sym14051003
crossref_primary_10_1016_j_compbiomed_2022_105210
crossref_primary_10_3390_app12104861
crossref_primary_10_1016_j_asoc_2022_109401
crossref_primary_10_2147_JMDH_S322431
crossref_primary_10_3390_antibiotics11060789
crossref_primary_10_1016_j_chemolab_2022_104750
crossref_primary_10_1007_s12652_021_03464_7
crossref_primary_10_1016_j_ibmed_2021_100034
crossref_primary_10_1016_j_eswa_2021_114997
crossref_primary_10_35741_issn_0258_2724_59_4_6
crossref_primary_10_1038_s41598_022_25397_7
crossref_primary_10_1007_s11042_024_19549_2
crossref_primary_10_1007_s11042_024_18789_6
crossref_primary_10_4102_safp_v65i1_5700
crossref_primary_10_3390_covid1010034
crossref_primary_10_1055_s_0041_1741371
crossref_primary_10_1016_j_isci_2024_111727
crossref_primary_10_1002_rcr2_785
crossref_primary_10_1016_j_pdpdt_2021_102473
crossref_primary_10_32604_cmc_2023_032192
crossref_primary_10_1109_OJIM_2023_3303944
crossref_primary_10_1080_19490976_2024_2342497
crossref_primary_10_3345_cep_2022_01179
crossref_primary_10_3390_info14060310
crossref_primary_10_1016_j_ipemt_2022_100008
crossref_primary_10_1186_s12879_025_10443_2
crossref_primary_10_32388_6I4GEC
crossref_primary_10_1007_s00521_022_08127_y
crossref_primary_10_1016_j_ccc_2021_05_003
crossref_primary_10_2478_rjim_2023_0013
crossref_primary_10_4103_cmi_cmi_68_23
crossref_primary_10_1142_S0218348X21502558
crossref_primary_10_1186_s12879_021_06941_8
crossref_primary_10_1016_j_asoc_2022_108610
crossref_primary_10_1016_j_rxeng_2021_03_006
crossref_primary_10_1016_j_bea_2022_100041
Cites_doi 10.1148/radiol.2020200463
10.3348/kjr.2020.0132
10.1016/j.clinimag.2020.04.001
10.1148/radiol.2020200230
10.1148/radiol.2020201237
10.1148/radiol.2020200269
10.1136/thoraxjnl-2017-211280
10.2214/AJR.20.23034
10.1128/JCM.00310-20
10.1016/j.chest.2020.04.003
10.1148/radiol.2020201754
10.1148/ryct.2020204002
10.1016/j.jacr.2020.02.008
10.1148/radiol.2462070712
10.1007/s00330-020-06967-7
10.1016/S0140-6736(20)30211-7
10.1177/0846537120914428
10.1016/S1473-3099(20)30086-4
10.2214/AJR.20.22975
10.1016/S0140-6736(20)30183-5
10.1186/s13054-020-2817-7
10.1148/radiol.2020200370
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12890-020-01286-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2466
EndPage 9
ExternalDocumentID oai_doaj_org_article_a18a68a76a0149d68e7204c9551b221c
PMC7491017
A636945096
32933519
10_1186_s12890_020_01286_5
Genre Journal Article
GeographicLocations Jordan
China
GeographicLocations_xml – name: Jordan
– name: China
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7TO
7XB
8FK
AZQEC
COVID
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-b08cfa761c094475ec1ab64a8b7ef351ffe49309702526a3a58f53beb6144b733
IEDL.DBID 7X7
ISSN 1471-2466
IngestDate Wed Aug 27 01:24:40 EDT 2025
Thu Aug 21 14:08:56 EDT 2025
Fri Jul 11 10:54:43 EDT 2025
Fri Jul 25 09:12:08 EDT 2025
Tue Jun 17 21:38:22 EDT 2025
Tue Jun 10 20:50:40 EDT 2025
Mon Jul 21 05:39:12 EDT 2025
Tue Jul 01 02:40:23 EDT 2025
Thu Apr 24 23:01:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-b08cfa761c094475ec1ab64a8b7ef351ffe49309702526a3a58f53beb6144b733
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9589-7759
OpenAccessLink https://www.proquest.com/docview/2444123454?pq-origsite=%requestingapplication%
PMID 32933519
PQID 2444123454
PQPubID 44785
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_a18a68a76a0149d68e7204c9551b221c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7491017
proquest_miscellaneous_2443519045
proquest_journals_2444123454
gale_infotracmisc_A636945096
gale_infotracacademiconefile_A636945096
pubmed_primary_32933519
crossref_citationtrail_10_1186_s12890_020_01286_5
crossref_primary_10_1186_s12890_020_01286_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-09-15
PublicationDateYYYYMMDD 2020-09-15
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-15
  day: 15
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pulmonary medicine
PublicationTitleAlternate BMC Pulm Med
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References N Chen (1286_CR22) 2020; 395
C Huang (1286_CR5) 2020; 395
HYF Wong (1286_CR14) 2019; 27
1286_CR19
1286_CR18
Y Fang (1286_CR8) 2020; 19
H Meng (1286_CR13) 2020; 12
M Chung (1286_CR4) 2020; 295
1286_CR9
DM Hansell (1286_CR15) 2008; 246
JFW Chan (1286_CR2) 2020; 58
Y Wang (1286_CR23) 2020; 19
1286_CR11
D Toussie (1286_CR29) 2020; 14
J Zhang (1286_CR10) 2020; 24
G Wu (1286_CR27) 2020; 13
S Salehi (1286_CR1) 2020; 215
H Shi (1286_CR25) 2020; 295
H Shi (1286_CR28) 2020; 20
S Zhou (1286_CR26) 2020; 214
M Warren (1286_CR16) 2018; 73
A Jacobi (1286_CR17) 2020; 64
T Ai (1286_CR7) 2020; 26
S Kooraki (1286_CR3) 2020; 17
A Bernheim (1286_CR12) 2020; 295
F Pan (1286_CR24) 2020; 295
SH Yoon (1286_CR6) 2020; 21
1286_CR20
1286_CR21
References_xml – volume: 295
  start-page: 200463
  year: 2020
  ident: 1286_CR12
  publication-title: Radiology.
  doi: 10.1148/radiol.2020200463
– volume: 21
  start-page: 494
  year: 2020
  ident: 1286_CR6
  publication-title: Korean J Radiol
  doi: 10.3348/kjr.2020.0132
– volume: 64
  start-page: 35
  year: 2020
  ident: 1286_CR17
  publication-title: Clin Imaging
  doi: 10.1016/j.clinimag.2020.04.001
– ident: 1286_CR18
– volume: 295
  start-page: 202
  year: 2020
  ident: 1286_CR4
  publication-title: Radiology.
  doi: 10.1148/radiol.2020200230
– ident: 1286_CR11
  doi: 10.1148/radiol.2020201237
– volume: 295
  start-page: 20
  year: 2020
  ident: 1286_CR25
  publication-title: Radiology
  doi: 10.1148/radiol.2020200269
– volume: 26
  start-page: 200642
  year: 2020
  ident: 1286_CR7
  publication-title: Radiology.
– volume: 73
  start-page: 840
  year: 2018
  ident: 1286_CR16
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2017-211280
– volume: 27
  start-page: 201160
  year: 2019
  ident: 1286_CR14
  publication-title: Radiology.
– volume: 13
  start-page: 1
  year: 2020
  ident: 1286_CR27
  publication-title: Eur Radiol
– volume: 215
  start-page: 1
  year: 2020
  ident: 1286_CR1
  publication-title: AJR.
  doi: 10.2214/AJR.20.23034
– volume: 19
  start-page: 200432
  year: 2020
  ident: 1286_CR8
  publication-title: Radiology.
– volume: 58
  start-page: e00310
  year: 2020
  ident: 1286_CR2
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00310-20
– ident: 1286_CR19
  doi: 10.1016/j.chest.2020.04.003
– volume: 14
  start-page: 201754
  year: 2020
  ident: 1286_CR29
  publication-title: Radiology.
  doi: 10.1148/radiol.2020201754
– ident: 1286_CR20
  doi: 10.1148/ryct.2020204002
– volume: 17
  start-page: 447
  year: 2020
  ident: 1286_CR3
  publication-title: J Am Coll Radiol
  doi: 10.1016/j.jacr.2020.02.008
– volume: 246
  start-page: 697
  year: 2008
  ident: 1286_CR15
  publication-title: Radiology.
  doi: 10.1148/radiol.2462070712
– ident: 1286_CR21
  doi: 10.1007/s00330-020-06967-7
– volume: 395
  start-page: 507
  year: 2020
  ident: 1286_CR22
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(20)30211-7
– ident: 1286_CR9
  doi: 10.1177/0846537120914428
– volume: 20
  start-page: 425
  year: 2020
  ident: 1286_CR28
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(20)30086-4
– volume: 214
  start-page: 1
  year: 2020
  ident: 1286_CR26
  publication-title: AJR
  doi: 10.2214/AJR.20.22975
– volume: 395
  start-page: 497
  year: 2020
  ident: 1286_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 24
  start-page: 119
  year: 2020
  ident: 1286_CR10
  publication-title: Crit Care
  doi: 10.1186/s13054-020-2817-7
– volume: 12
  start-page: S0163
  year: 2020
  ident: 1286_CR13
  publication-title: J Inf Secur
– volume: 19
  start-page: 200843
  year: 2020
  ident: 1286_CR23
  publication-title: Radiology.
– volume: 295
  start-page: 715
  year: 2020
  ident: 1286_CR24
  publication-title: Radiology.
  doi: 10.1148/radiol.2020200370
SSID ssj0017853
Score 2.5761018
Snippet Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis and follow...
Background Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in diagnosis...
Abstract Background Chest CT scan and chest x-rays show characteristic radiographic findings in patients with COVID-19 pneumonia. Chest x-ray can be used in...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 245
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Asymptomatic
Chest
Chest x-rays
Child
Child, Preschool
Computed tomography
Consolidation
Coronavirus Infections - diagnostic imaging
Coronaviruses
COVID-19
Demography
Diagnosis
Female
Humans
Illnesses
Lung
Lung - diagnostic imaging
Male
Medical imaging
Middle Aged
Pandemics
Patients
Physiological aspects
Pleural effusion
Pneumonia
Pneumonia, Viral - diagnostic imaging
Polymerase chain reaction
Pulmonology
Radiography, Thoracic
Respiratory diseases
Retrospective Studies
Reverse transcription
Severe acute respiratory syndrome coronavirus 2
Time Factors
Tomography, X-Ray Computed
X-rays
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SB_FF1PqxtUoKgg8SuntJJtnHelpaoQpipW8hyWb14NiW7h3of-_Mbu64RdCXvu4kkEzmcyf5DWNvfFtCC2USHkwjVAIQtdVK-BBx3XUK0FJF9-IznF2qT1f6aqfVF90JG-GBR8Yd-8p6sN6Ap2C-AZuorUqs0dOH2ayKZH3R522SqVw_MOiFNk9kLBz3FdXTBKVKZJBB6IkbGtD6_7bJO05pemFyxwOdPmIPc-jIT8YlP2b3UveE3b_IxfF99nVOva_4L3Hrf_OhFt396LnvGp7xp5Z8iarNx7e-PV90PKOq9px-x_L5l-_nH0RV85surVE8F_4puzz9-G1-JnLLBBE1yJUIpY0tMquKmLYpo1OsfADlbTCplbpq26RqWdYGQ50ZeOm1bbUMeCSYWAUj5TO211136QXjECAZ39ooG6lSI4OMIZnQRF1GzDFMwaoNB13MeOLU1mLphrzCghu57pDrbuC60wV7t51zM6Jp_HP0ezqY7UhCwh4-oHy4LB_uf_JRsLd0rI70FZcXfX52gJsk5Ct3AhJqRSA4BTucjEQ9i1PyRjBc1vPeYXCk0PcrrQp2tCXTTLq71qXr9TCGuiBi7Fyw56McbbckMdoiYsHMRMIme55SusXPAQXcqJrM6cFdMOklezAblKMWlT5ke6vbdXqFwdYqvB706g_xZyMf
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nCeKL-G31lAiCDxJtN599EDlXj1NYBXHl3kKSpufC0j23u3D33zuTtusVj3vtJJCZzGRmOslvCHnl6lzVKo_MKV0xEZVipZGCOR9g3WX0qsaK7uybOp6LryfyZI8M7Y56AbZXpnbYT2q-Xr49_3PxAQz-fTJ4o961BVbLGCZCeNwqJm-Qm-CZNBrqTPyrKmjwTcPDmSvnjZxTwvD__6S-5KrG1ygv-aWju-ROH1DSw04D7pG92Nwnt2Z9yfwB-THFjlj0nK3dBU0V6ua0pa6paI9KtaRLMHjavQBu6aKhPdZqS_EnLZ1-__XlEytKetbELSjtwj0k86PPP6fHrG-kwIJUfMN8bkLttCoCJHNCyxgK55VwxutYc1nUdRQlz0sNAdBEOe6kqSX3sFGQbnnN-SOy36ya-IRQ5VXUrjaBV1zEinsefNS-CjIPkHnojBSDBG3oUcax2cXSpmzDKNtJ3YLUbZK6lRl5s5tz1mFsXDv6I27MbiTiY6cPq_Wp7c3NusI4ZYBlhylgpUzEZjyhhPjQTyZFyMhr3FaLegXLC65_jABMIh6WPVRclQKhcTJyMBoJ1hfG5EEx7KC8FkImARGBkCIjL3dknIk32pq42qYx2BsRIuqMPO70aMcShxgMiRnRIw0b8TymNIvfCRtcixIP2afXL-sZuT1Jal-yQh6Q_c16G59DcLXxL5LF_AVUrB7V
  priority: 102
  providerName: Scholars Portal
Title Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia
URI https://www.ncbi.nlm.nih.gov/pubmed/32933519
https://www.proquest.com/docview/2444123454
https://www.proquest.com/docview/2443519045
https://pubmed.ncbi.nlm.nih.gov/PMC7491017
https://doaj.org/article/a18a68a76a0149d68e7204c9551b221c
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dixMxEA96B-KL-O2eZ4kg-CDhus3nPsm13nEKPaV4UnwJSTZ7Fsq2dls4_3sz2XS9RbiXfdgkkElmJvOR_Aahd6YaikoMPTFCloR5IUihOCPGujDvwltRQUZ3eikurtiXOZ-ngFuTrlXudWJU1OXKQYz8JBxDLGhZxtnH9W8CVaMgu5pKaNxHhwBdBle65LxzuKDwPN0_lFHipMkhq0bAYQK1LAjvHUYRs_9_zXzraOpfm7x1Dp0_Ro-SAYlP2x1_gu75-il6ME0p8mdoNoEKWPiGbMwfHDPS9XWDTV3ihEK1xMsg4Lh98dvgRY0TtmqDISiLJ19_fP5E8gKva78LVC_Mc3R1fvZ9ckFS4QTiuKBbYofKVUaK3AXnjUnuXW6sYEZZ6SvK86ryrKDDQgaDZyQMNVxVnNqwMcG9spLSF-igXtX-FcLCCi9NpRwtKfMltdRZL23p-NAFT0NmKN-voHYJVRyKWyx19C6U0O2q67DqOq665hn60I1Zt5gad_Yew8Z0PQEPO_5Yba51Ei9tcmWECiQbcPlKoTwU33FFsAftaJS7DL2HbdUgtWF6zqTHB4FIwL_Sp4KKggEUToaOez2DtLl-854xdJL2Rv_jzQy97ZphJNxgq_1qF_tALcRgQWfoZctHHUk02FzQmCHZ47Aezf2WevErYoFLVoBSPbp7Wq_Rw1Fk-4Lk_BgdbDc7_yYYU1s7iBIzQIfjs8tvs0EMSYTvlKnwnY1__gVQ6yAe
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTQJeEN8EBhgJxAOy1sQfSR4Q2rpNLVsLmja0N892nFGpSkvTCvZP8Tdyl4-yCGlve805kn2-r5_PviPkncl7Klc9z4yKMya8UixNpGDGOph36q3KMaM7GqvBmfhyLs83yJ_2LQxeq2xtYmWos5nDM_IdcEMCrKyQ4vP8J8OuUZhdbVto1GJx5K9-AWQrPw33YX_fR9HhwWl_wJquAsxJxZfM9hKXG0DvDpCNiKV3obFKmMTGPucyzHMvUt5LY4gGImW4kUkuuYVZA_awMR6AgsnfEhygzCbZ2jsYfztZ5y1i8H7t05xE7ZQh5vEYQjR0BIrJjvurugT87wuuOcPuRc1rnu_wAbnfhKx0t5axh2TDF4_InVGTlH9MTvrYc4v-ZgtzRasceHFZUlNktKl7NaVTMCm0fmNc0klBm2quJcVjYNr_-n24z8KUzgu_Aj5PzBNyditMfUo2i1nhnxOqrPKxyRPHMy58xi131sc2c7LnANvEAQlbDmrX1DHHdhpTXeGZROma6xq4riuuaxmQj-t_5nUVjxtH7-HGrEdiBe7qw2xxqRuF1iZMjEpgyQZBZqYSj-1-XAoRqI2i0AXkA26rRjsB03Omee4Ai8SKW3pXcZUKLL4TkO3OSNBv1yW3gqEb-1Lqf9oQkLdrMv6Jd-YKP1tVY7D7IsTsAXlWy9F6SRyiPCQGJO5IWGfNXUox-VFVH49Fimb8xc3TekPuDk5Hx_p4OD56Se5FlQqkLJTbZHO5WPlXEMot7etGfyi5uG2V_QtokVlJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chest+x-ray+findings+and+temporal+lung+changes+in+patients+with+COVID-19+pneumonia&rft.jtitle=BMC+pulmonary+medicine&rft.au=Rousan%2C+Liqa+A&rft.au=Elobeid%2C+Eyhab&rft.au=Karrar%2C+Musaab&rft.au=Khader%2C+Yousef&rft.date=2020-09-15&rft.pub=BioMed+Central&rft.eissn=1471-2466&rft.volume=20&rft.spage=1&rft_id=info:doi/10.1186%2Fs12890-020-01286-5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon